GTS Securities’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,000
Closed -$235K 2101
2024
Q3
$235K Sell
16,000
-3,000
-16% -$41.8K ﹤0.01% 3514
2024
Q2
$274K Buy
+19,000
New +$304K ﹤0.01% 3204
2024
Q1
Sell
-11,700
Closed -$174K 3997
2023
Q4
$174K Sell
11,700
-3,500
-23% -$39.6K ﹤0.01% 3614
2023
Q3
$171K Buy
+15,200
New +$177K ﹤0.01% 3462

Other funds holding ELAN

GTS Securities's ELAN Position: Q4 2024 in Review

GTS Securities sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 81,201 shares — an estimated $1.19M sold.

GTS Securities first reported a position in ELAN in Q2 2023 and held it in 6 quarters. The position peaked at $1.86M in Q4 2023. 393 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • GTS Securities reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 81,201 Elanco Animal Health shares in Q4 2024, an estimated $1.19M.
  • GTS Securities first reported a position in Elanco Animal Health in Q2 2023 and held it in 6 quarters.
  • GTS Securities's Elanco Animal Health position peaked at $1.86M in Q4 2023.
  • 393 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.